Plasma malondialdehyde (MDA) levels in breast and lung cancer patients
- 1 April 2001
- journal article
- research article
- Published by Hindawi Limited in Journal of Clinical Pharmacy & Therapeutics
- Vol. 26 (2) , 141-144
- https://doi.org/10.1046/j.1365-2710.2001.00334.x
Abstract
Objective: To measure the levels of malondialdehyde (MDA), a marker of lipid peroxidation, in patients with breast and lung cancer. Method: Analysis of plasma MDA, and serum uric acid, albumin, cho...Keywords
This publication has 15 references indexed in Scilit:
- Prospects for the prevention of free radical disease, regarding cancer and cardiovascular diseaseBritish Medical Bulletin, 1993
- Decreases in Serum Cholesterol Levels in Advanced Lung CancerRespiration, 1993
- Antioxidant Functions of VitaminsAnnals of the New York Academy of Sciences, 1992
- Evidence of lipid peroxidation in premenopausal women with mammographic dysplasiaCancer Letters, 1990
- Plasma lipids in premenopausal women with mammographic dysplasiaBritish Journal of Cancer, 1989
- Interaction of lipid peroxidation products with DNA. A reviewMutation Research/Reviews in Genetic Toxicology, 1988
- Albumin—An important extracellular antioxidant?Biochemical Pharmacology, 1988
- Free Radicals and Antioxidant Protection: Mechanisms and Significance in Toxicology and DiseaseHuman Toxicology, 1988
- Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acidBiochemical Journal, 1986
- Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis.Proceedings of the National Academy of Sciences, 1981